An educated citizenry is a vital requisite for our survival as a free people.
Search
Close
  • Support
  • Store
  • About
  • ThinkCivics+
Menu
  • Support
  • Store
  • About
  • ThinkCivics+
Sign In
Subscribe
Support
Home Health

Breaking: FDA panel votes 16-3 against booster Vaccines for the general public

An influential FDA advisory committee on Friday rejected a proposal to distribute booster shots of Pfizer and BioNTech’s Covid-19 vaccine to the general public.

ThinkCivics Newswire by ThinkCivics Newswire
September 17, 2021
in Health
Reading Time: 2 mins read
0
0
Breaking: FDA panel votes 16-3 against booster Vaccines for the general public

Liesl Eibschutz, a medical student from Dartmouth University, loads a syringe with Pfizer COVID-19 vaccine before giving it to people on the first day that people ages 16 and up can receive the vaccine at Kedren Health on Thursday, April 15, 2021 in Los Angeles, CA. Allen J. Schaben | Los Angeles Times | Getty Images

RelatedPosts

Want to Avoid the ICU for COVID? Just Take This One Little Pill

‘All Hell’s Going To Break Loose’: Jordan Peterson Predicts Dire Consequences For Hospitals Transitioning Children

An influential Food and Drug Administration advisory committee on Friday rejected a proposal to distribute booster shots of Pfizer and BioNTech’s Covid-19 vaccine to the general public, paring back those plans to unanimously recommend the third shots to people age 65 and older and other vulnerable Americans.

“It’s likely beneficial, in my opinion, for the elderly, and may eventually be indicated for the general population. I just don’t think we’re there yet in terms of the data,” said Dr. Ofer Levy, a vaccine and infectious disease specialist at Boston Children’s Hospital.

The panel voted 16-2 against distributing the vaccines to Americans 16 and older, before unanimously embracing an alternate plan to give boosters to older Americans and those at a high risk of suffering from severe illness if they get the virus. That’s previously included people with diabetes, heart disease, obesity and other so-called comorbidities.

Pfizer’s stock closed down 1.3%, while shares of BioNTech fell 3.6%.

The nonbinding decision by the FDA’s Vaccines and Related Biological Products Advisory Committee comes as the Biden administration has said it wants to begin offering booster shots to the general public as early as next week, pending authorization from U.S. health regulators. While the agency hasn’t always followed the advice of its committee, it often does. A final FDA decision could come in a matter of hours. The Centers of Disease Control and Prevention has scheduled a two-day meeting next week to discuss plans to distribute the third shots in the U.S.

Source CNBC

Vaccines and Related Biological Products Advisory Committee Meeting

ThinkCivics Newswire

ThinkCivics researches, examines, and reports on issues that matter most. We deliver explanative, fearless, and insightful analysis for public consumption.

thinkcivics.com
Tags: Covid-19FDAvaccine boosters
Next Post
Australia: No Vaccine means No Freedom

Australia: No Vaccine means No Freedom

CCP to the US: Can’t keep the ‘Chinese people in the cage of poverty forever’

CCP to the US: Can't keep the 'Chinese people in the cage of poverty forever'

China Lab Created Coronavirus ‘10,000 Times Stronger Than Usual’

China Lab Created Coronavirus ‘10,000 Times Stronger Than Usual’

Facebook Twitter Rss
  • About
  • Advertise
  • Submissions
  • Contact Us
  • About
  • Advertise
  • Submissions
  • Contact Us
  • Policies & standards
  • Privacy policy
  • Terms and conditions

© 2023 ThinkCivics Media, LLC. All Rights Reserved.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
  • Login
  • Sign Up
  • Cart
  • Home
  • About
  • Store
  • Contact Us
  • Support Us
  • Join
Facebook Twitter Rss
© 2022 ThinkCivics Media. All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

OR

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In